Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 2 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
HER2-low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis.
Cancer. 2024 Mar 15;130(6):851-862. doi: 10.1002/cncr.35101. Epub 2023 Nov 7.
Cancer. 2024.
PMID: 37933913
Treatment patterns and clinical outcomes of chidamide combined with endocrine therapy in hormone receptor-positive, HER2-negative metastatic breast cancer: A real-world multicenter study.
Li D, Jin Y, Lin M, Zeng C, Guo Q, Liu Y, Zhang J.
Li D, et al.
Cancer Med. 2024 Feb;13(4):e6762. doi: 10.1002/cam4.6762.
Cancer Med. 2024.
PMID: 38457252
Free PMC article.
Item in Clipboard
Cite
Cite